Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.

Wen-Chi Chen Yan-Hua ChenPing-I HsuFeng-Woei TsayHoi-Hung ChanJin-Shiung ChengKwok-Hung Lai

Published in: BioMed research international (2014)

Warfarin was associated with a significant incidence of GIB in Taiwanese patients. The intensity of anticoagulation should be monitored closely during warfarin therapy, especially in patients with risk factors of GIB.

Keyphrases

risk factors
atrial fibrillation
end stage renal disease
venous thromboembolism
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
mesenchymal stem cells
high intensity
oral anticoagulants